{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:38:17Z","timestamp":1790141897070,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lansea.2024.100527","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T03:51:24Z","timestamp":1736049084000},"page":"100527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Improving clinical care of patients in Nipah outbreaks: moving beyond \u2018compassionate use\u2019"],"prefix":"10.1016","volume":"33","author":[{"given":"Md Zakiul","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Rojek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Horby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lansea.2024.100527_bib3","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S1473-3099(23)00707-7","article-title":"Nipah virus disease: what can we do to improve patient care?","volume":"24","author":"Hassan","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.lansea.2024.100527_bib4","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMoa1805376","article-title":"Transmission of Nipah virus\u201414 years of investigations in Bangladesh","volume":"380","author":"Nikolay","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lansea.2024.100527_bib5","series-title":"Prioritizing diseases for research and development in emergency contexts","year":"2024"},{"issue":"6","key":"10.1016\/j.lansea.2024.100527_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ana.1062","article-title":"Treatment of acute Nipah encephalitis with ribavirin","volume":"49","author":"Chong","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lansea.2024.100527_bib7","first-page":"674","article-title":"The magic of randomization versus the myth of real-world evidence","volume":"382","author":"Collins","year":"2020","journal-title":"Massachusetts Med Soc"},{"issue":"3","key":"10.1016\/j.lansea.2024.100527_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1099\/vir.0.017269-0","article-title":"Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection","volume":"91","author":"Freiberg","year":"2010","journal-title":"J\u00a0Gen Virol"},{"issue":"5","key":"10.1016\/j.lansea.2024.100527_bib9","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.50.5.1768-1772.2006","article-title":"Poly (I)-poly (C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection","volume":"50","author":"Georges-Courbot","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.lansea.2024.100527_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29559","article-title":"Clinico-epidemiological presentations and management of Nipah virus infection during the outbreak in Kozhikode district, Kerala state, India 2023","volume":"96","author":"As","year":"2024","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.lansea.2024.100527_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01732-5","article-title":"Compassionate drug (mis) use during pandemics: lessons for COVID-19 from 2009","volume":"18","author":"Rojek","year":"2020","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.lansea.2024.100527_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003872","article-title":"Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: a national registry study","volume":"18","author":"Senefeld","year":"2021","journal-title":"PLoS Med"},{"issue":"10289","key":"10.1016\/j.lansea.2024.100527_bib15","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lansea.2024.100527_bib16","doi-asserted-by":"crossref","first-page":"j2986","DOI":"10.1136\/bmj.j2986","article-title":"Lassa fever","volume":"358","author":"Houlihan","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.lansea.2024.100527_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010289","article-title":"Ribavirin for treating Lassa fever: a systematic review of pre-clinical studies and implications for human dosing","volume":"16","author":"Salam","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"10121","key":"10.1016\/j.lansea.2024.100527_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(17)31795-6","article-title":"Evidence-based guidelines for supportive care of patients with Ebola virus disease","volume":"391","author":"Lamontagne","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lansea.2024.100527_bib19","series-title":"Asia. WHOROfS-E. WHO South-East Asia regional Strategy for the prevention and control of Nipah virus infection","first-page":"2023","year":"2023"},{"issue":"10191","key":"10.1016\/j.lansea.2024.100527_bib20","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/S0140-6736(19)31509-0","article-title":"No cause identified for death of children in Bihar, India","volume":"393","author":"Chatterjee","year":"2019","journal-title":"Lancet"},{"issue":"10202","key":"10.1016\/j.lansea.2024.100527_bib21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(19)31811-2","article-title":"Recurring acute encephalitis syndrome outbreaks in Bihar, India","volume":"394","author":"Ghosh","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lansea.2024.100527_bib22","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/S2214-109X(22)00079-1","article-title":"An algorithmic approach to identifying the aetiology of acute encephalitis syndrome in India: results of a 4-year enhanced surveillance study","volume":"10","author":"Ravi","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.lansea.2024.100527_bib23","doi-asserted-by":"crossref","first-page":"e596","DOI":"10.1016\/S2214-109X(22)00123-1","article-title":"Strengthening public health systems for diagnosing patients with acute encephalitis syndrome of unidentified cause","volume":"10","author":"Gupta","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lansea.2024.100527_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2020.07.026","article-title":"Hospital-based surveillance for Japanese encephalitis in Bangladesh, 2007\u20132016: implications for introduction of immunization","volume":"99","author":"Paul","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.lansea.2024.100527_bib25","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/cid\/ciad417","article-title":"Global landscape of encephalitis: key priorities to reduce future disease burden","volume":"77","author":"Granerod","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lansea.2024.100527_bib26","series-title":"Why encephalitis matters? Report of the virtual meeting, 28-29 June 2022","year":"2023"},{"issue":"9452","key":"10.1016\/j.lansea.2024.100527_bib28","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/S0140-6736(04)17580-6","article-title":"Chandipura virus, encephalitis, and epidemic brain attack in India","volume":"364","author":"Mishra","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lansea.2024.100527_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.lansea.2024.100527_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41597-022-01534-9","article-title":"ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19","volume":"9","author":"Etienne","year":"2022","journal-title":"Sci Data"},{"issue":"39","key":"10.1016\/j.lansea.2024.100527_bib31","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.vaccine.2021.08.027","article-title":"Assessing the feasibility of Nipah vaccine efficacy trials based on previous outbreaks in Bangladesh","volume":"39","author":"Nikolay","year":"2021","journal-title":"Vaccine"},{"issue":"494","key":"10.1016\/j.lansea.2024.100527_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau9242","article-title":"Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge","volume":"11","author":"Lo","year":"2019","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.lansea.2024.100527_bib33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/infdis\/jiad275","article-title":"Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)","volume":"228","author":"Jittamala","year":"2023","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.lansea.2024.100527_bib34","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S2666-5247(23)00398-1","article-title":"Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis","volume":"5","author":"Elias","year":"2024","journal-title":"Lancet Microbe"},{"issue":"14","key":"10.1016\/j.lansea.2024.100527_bib35","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJMsb1905390","article-title":"Creating a framework for conducting randomized clinical trials during disease outbreaks","volume":"382","author":"Dean","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"741","key":"10.1016\/j.lansea.2024.100527_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl2055","article-title":"Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates","volume":"16","author":"Zeitlin","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lansea.2024.100527_bib37","article-title":"Nipah virus therapeutics: a systematic review to support prioritisation for clinical trials","author":"Chan","year":"2024","journal-title":"medRxiv"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277236822400177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277236822400177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T04:15:52Z","timestamp":1739160952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277236822400177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":32,"alternative-id":["S277236822400177X"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2024.100527","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving clinical care of patients in Nipah outbreaks: moving beyond \u2018compassionate use\u2019","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2024.100527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100527"}}